Devereux N Saller
Affiliation: University of Virginia
- Current methods of prenatal screening for Down syndrome and other fetal abnormalitiesDevereux N Saller
Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA
Clin Obstet Gynecol 51:24-36. 2008..These choices can be confusing both to both patients and providers. The following discussion is meant to outline the various options in prenatal screening, and their individual advantages and disadvantages...
- Genetic screening in a university clinic: impact of primary languageAngela F Hawk
Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908 0760, USA
Prenat Diagn 31:846-52. 2011....
- Screening for fetal aneuploidy: is maternal age relevant?Angela F Hawk
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Medical University of South Carolina, Charleston, South Carolina, USA
Clin Obstet Gynecol 55:217-25. 2012..The use of genetic screening in a general population should be examined in terms of cost effectiveness without sacrificing patient preference and autonomy...
- Patient preferences for screening in the first trimesterErika F Werner
Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, USA
Prenat Diagn 28:1251-5. 2008..We also hypothesized that screening results might alter patients' future preferences...
- A checklist for timeout on labor and delivery: a pilot study to improve communication and safetyKathie L Hullfish
Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA, USA
J Reprod Med 59:579-84. 2014..To assess the impact on staff communication of a standardized checklist for timeout for patients undergoing a trial of labor after cesarean section and/or elective induction at term...
- Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsiaBruno M Polliotti
Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York 11713, USA
Obstet Gynecol 101:1266-74. 2003..To determine whether alterations in second-trimester maternal serum cytokine concentrations can identify women at risk for developing severe, early-onset preeclampsia...
- Prenatal screening for Down syndrome: current and future methodsJacob A Canick
Division of Prenatal and Special Testing, Department of Pathology and Laboratory Medicine, Women and Infants Hospital, Brown Medical School, Providence, RI 02905, USA
Clin Lab Med 23:395-411. 2003..In the next few years, that goal will probably be achieved...